Iofina plcInterim Results September 2010

Key Personnel

• Lance J. Baller, CEO and President– Former Managing Partner of Shortline Equity Partners, Inc.; a former Vice President of the investment banking firms UBS AG and

Morgan Stanley– Significant investment, audit and corporate governance committee experience

• Michael Coddington, Finance Director– Bachelor of Business Administration degree, Finance and Accounting, University of Cincinnati.– Over 30 years of experience as from Controller to CFO for manufacturing and production companies

• Forest D. Dorn, CEO and President of Iofina Natural Gas– Former Member/Manger of Avanti Exploration, LLC.; Former Senior Vice President Corporate Services of Forest Oil Corporation– Over 30 years of broad oil and gas experience

• Dr. Tom Becker, PhD, CEO and President of Iofina Chemical– Former VP of Research and Development for H&S Chemical (acquired by Iofina)– Extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and the inventor on

several chemical patents, including Wellhead Extraction Technology® (WET®)

• Dr. Chris Fay, CBE, PhD,BSc, C.Eng, FREng, FRSE, FICE & FEINon-Executive Chairman

– Former Chairman and Chief Executive of Shell U.K. Limited– Former Non-Executive Chairman of Expro International Group plc sold to Candover for £1.8bn in 2008– Former Non-Executive Director of Anglo-American plc (LSE: AAL; £16.5bn cap)

• Jamison R. Davis, COO of US subsidiaries– Previously with Intel Capital - New Products Initiatives– Chartered Financial Analyst – Has been with Iofina since late 2006

* Further detail on management in Appendix

2

3

The importance of Iodine

• Iodine compounds are used in CT scans, and X-rays, helping doctors to diagnose patients effectively

• Iodine compounds are added to paints and protective coatings to prevent the growth of moulds and other pathogens

• Iodine compounds are added to cosmetic products to prevent the growth and transfer of harmful bacteria

• Iodine formulations protect dairy cows and humans from infections that can be transferred through milk

• Iodine compounds are used to manufacture high-tech LCDs

• Iodine derivatives are used to produce many essential pharmaceuticals, giving doctors powerful new drugs to fight disease

• Iodine compounds are used as a more effective tool in controlling pathogens and weeds in food crops due to Iodine’s lack of ozone layer depleting properties

• Iodine is added to table salt, helping to ensure adequate daily intake of this vital nutrient

• Insufficient Iodine causes Iodine Deficiency Disorder –medically proven to cause health problems including cretinism and goitre

Iodine is essential for life and industry

4

IodineGrowing Demand

•Multiple industries and products require Iodine with 2009 production of 25,500mt*

• Iodine derivatives market worth $2.5-3bn pa offering substantial profit margins

•State of California became 48th state to permit the use of Methyl Iodide as pesticide on 3 May 2010

•Growth being accelerated by new markets (LCD screens) and new consuming countries

•From 2000 to 2008 the CAGR of Iodine has been 6.5%* (*source: SQM)

Source Data: Blend of USGS, SQM, Armour Associates, and others

5

IodineA Valuable Resource

Chile 53% of global production mined from caliche ore

SQM (NYSE listed; $9.02bn cap; 25% market share)Cosayach (Privately held and second largest in the world)Atacama (TSX listed; Sales $29.4m; Profits $2.9m) Toyota Tsucho Corp of Japan to begin production in Chile in 2011

Source: SQM

The global Iodine supply is dominated and controlled by two countries: Japan and Chile

Japan 21% of global production. 5 players producing from gas brine water

Ise Chemical Co, Ltd. (Sales $149m; Profits $10m)Kanto Natural Gas Development, Co, Ltd (Sales $559m; Profits $32m)Nippoh Chemicals Co ($5.6m cap)

US5% of global production all from gas brine in the Anadarko Basin in Oklahoma in which the producers were purchased by the Japanese

US is required to import over 80% of annual consumption

2009 Iodine Production (25,500MT)

58%

1.5.

Worldwide estimated consumption of Iodine by Region and Country

2.

3.

4.

6

Iodine Still in Bull Cycle

•Iodine pricing has increased over 100 per cent since 2002•2010 pricing indications from the market are firm•Tight supply forecasted in short-to-medium term•Price increases reflect market conditions•Iodine derivatives chemicals have potential to enhance profit margins

Data from USGS Minerals Report

2010 Interim Results Highlights

• Strengthened management reorganization completed

• Iofina Chemicals profitable despite the challenges faced in repositioning the Chemical business and the economic slowdown. First Half sales at Iofina Chemical £6.0 million ($8.9 million USD) comfortably exceeded our budget of £4.8 million ($7.3 million USD), which is the highest in Company history.

• Successful rollout of Mid Stream Iodine Extraction Business Plan with the execution three Iodine Extraction and Collection Agreements

• Three PODS deployed at the during subsequent period

• Successfully completion and hookup of 12 wells with the Atlantis field

• Larger scale roll out in Atlantis underway; first iodine production March 2010

• Surface Discharge permit awarded May 2010

7

8

Iofina

The Company

•Iofina is focused on establishing itself as a material gas and Iodine producer through its three core businesses:

–Speciality Chemical division with vertical integration in Iodine derivatives and other halogens

–Processing of mid stream brine streams–Company owned production of natural

gas and Iodine (Atlantis c.290,000 net acres)

Iofina plc

Specialized Iodine

Derivatives

Third Party Iodine

Collection and

Extraction

Company Owned

Natural Gas and Iodine Production

9

Mid Stream Iodine Collection•Installation of 3 PODs

•Low gas price increased costs for water disposal presents strong economic case for extracting value from waste brine streams

•WET® (Wellhead Extraction Technology®)

–Developed by Iofina

–Lower cost of collection

•Currently able to demonstrate working product at Atlantis and in California

•Will add significant Iodine volumes to Iofina’s production with limited capital commitment.

•Iofina retains 100% of the raw Iodine

•Iofina retains 80% to 90% of the gross revenue depending on OPEX

•Gross revenue ranges between £0.10 and £0.31 per barrel

10

Mid Stream Iodine Extraction Update

• Four Iodine Collection and Extraction Agreements (ICE) executed•Three POD deployed and operating

•Fourth POD being outfitted for next location•Two additional awaiting final engineering for site specific deployment

• Ongoing engineering of filtration system•Develop solution for operational issues encountered

•Variation in brine stream chemical make up•Local operational idiosyncrasies•Filtration variation•Absorption media

• Development of potential Joint Venture synergistic to Iofina Chemical•Ongoing negotiation to secure additional ICE agreements•Incorporating improvements to POD design and functionality

Startup Initial Checklist

• Most effective Absorption material– Temperature– Chlorides– Hydrocarbons

• Comprehensive filtration solutions– Outsourced engineering– Cost driven approach– Incorporation of additional filtration and

pretreatment

• Chemical “interference” • Oxidation of other inorganic

material

• Improved communication and understanding of ongoing operations

• Developed comprehensive and standardized testing procedures

11

12

11

24

38 73

88

17

26 58

188 26

2

£49 £1

43

£300

£492 £5

89

£87 £1

90

£491

£1,3

57

£1,8

49

-

200

400

600

800

1,000

1,200

1,400

1,600

1,800

2,000

Mid Stream Production Values

Iodine Recovered - Per Year (MT)

Annualized Net Income ( X 1000)

Barrels per day (X 100)

$27.50/70% Efficiency

13

Atlantis ProspectAn area of widespread gas discoveries associated with large volumes of Iodine rich, brine. Iofina’s WET® technology is unlocking the value of this brine, by extracting the Iodine and by providing new source of fresh water for the region. This triple revenue approach substantially improves the economics of the Atlantis project

•CPR reports estimate recoverable gas and Iodine of 98 Bcf and 37.2m kg 35 BBW based on c.30,000 acres

•Initial Development Phase complete – Completed 10 vertical wells

– Extraction & stripping facility completed

•Montana Department of Environmental Quality approved Iofina to discharge 30,000 bwpd water after treatment into the Fresno Reservoir Effective June 1, 2010

• Preparing Phase 2 Development Plan

14

Iofina Atlantis Development -Phase 2

• Finalize Drilling and Completion plan–Horizontal vs. vertical–Well bore and tubular size–Separation & Compression–Fracture stimulation –Artificial lift

•Gas lift•ESP

• Water Development–Preliminary engineering and feasibility study for location of facility

–Filing for water rights in Montana and North Dakota

Atlantis Water • Large water resource (35 billion barrels) co-produced with natural gas and iodine

development• Water proven to be economically treatable

– Low organics, sulfates and TDS• Would be available at several points vs. single location for a well (multiple

withdrawal points on river)• Potential storage in reservoirs along Missouri river• Other beneficial uses: US Fish and Wildlife, power generation, agriculture hydraulic

fracturing• Iofina has already achieved necessary permits for discharge into Missouri River and

injection of concentrate

15

16

Iodine Chemical

•Strong vertical positions in the £1.67–2bn pa Iodine derivatives market

•Forecast for 2010 is robust with sales 30-35% higher than in 2009

•The first half of the year sales were £6 million ($8.9 million USD is the highest in that company’s history

• Profit margins have improved YTD for 2010 with EBITDA of £.671 million ($1.01 million USD) and Net Income of £.421 million ($.635 million USD)

•the Company is delivering innovative products and continued growth in existing products

Major Product Mix of Iofina Chemical:

Methyl Iodide (soil fumigant, chemical intermediate)Hydriodic Acid (disinfectant, teat dip, acetic acid manf.)IPBC (fungicide for paints, coatings, cosmetics)Trichloromelamine (U.S. EPA registered disinfectant)Lampricide (U.S. and Canadian registered, sea lamprey control)Methyl Fluoride (etchant for computer chip manufacturing) Chloramine-T (antiseptic, odor control agent, cutting oil additive)

Organic iodides are more difficult to manufacture and generally carry higher margins with secure Iodine supplies (IPBC, Methyl Iodide & others)Iofina Chemical has long term contracts with large companies for the supply of IPBC, Methyl Iodide, Trichloromelamine and other products

17

Iofina Chemical Derivatives•New management team (CEO, VP and CFO) at Iofina Chemical

– Tom Becker promoted to CEO (former VP of Iofina Chemical and WET® listed patent inventor)

– Kurt Jones promoted to VP, has been instrumental in sales effort and enhancing profit margins

•Implemented initiatives to recover profit margins by re-pricing•Cost approval controls initiated by the Board (December 2009)• £250,000 capacity improvements•We have seen softness in the Specialty Chemical business within

the last thirty days . We anticipate this will be short lived but the remainder of the year we anticipate weaker demand that will affect the second half of the year.

• Full Research & Development staff to support Iodine extraction, Mid Stream business and to bring new products to market

•Executed New 5 year contract for key product

•Move to higher margin products progressing nicely

• the Company is delivering innovative products and continued growth in existing products

18

2010 Focus

Substantial progress expected in three core businesses:• Execution of existing contracts

–Continue to contract for more sites–Positive cash flow–Pursue Joint Venture opportunities

• Iodine Chemical Derivatives–Deliver stronger margins–Establish new highly profitable niche products–Strong support on mid stream brine business

• Generate income from Atlantis prospect–Reduce Operating Expense–Phase 2 designed to increase production–Water Development

Well placed to become a material gas, water and Iodine producer

Iofina plcAppendix

19

Atlantis Brine and Treatability

•Atlantis is a regional, transitional resource of brackish water natural gas

•Atlantis water is absent of organics, sulfates and low in TDS, however it is not considered a beneficial-use water resource due to elevated TDS, depth and content of biogenic gas (pure methane)

•RO treatment is achievable and economical

Relevant publications:

•Pei Xu, Jörg E. Drewes, Dean Heil, Beneficial use of co-produced water through membrane treatment: technical-economic assessment, Desalination 225 (2008) 139–155•Jörg E. Drewes, Pei Xu, Dean Heil, Gary Wang, Multi-beneficial use of produced water through high-pressure membrane treatment and capacitive deionization. Final Report 2008.

Well Located in Core Area

20

MPDES

•Permitted to Discharge 30,000 barrels of water per day (1.26 million gallons/3.87 acre-feet)- Permit can be amended for larger volumes per day for treated water

•Endorsed by U.S. Fish and Wildlife Services for Bowdoin Wildlife Refuge located along the Missouri River-Iofina to provide fresh water in return for storage rights

•Water treatment facility will be located on the west bank of the Fresno Reservoir, and the Milk River, a water-short tributary of the Missouri River

•Fresno Reservoir has usable capacity of 65.8 billion gallons. Water is managed and delivered by the Bureau of Reclamation

•Produced water (treated) is considered a ‘new’ water resource and can be appropriated for beneficial use (a water right can be filed)

Timeline•Initial Iofina Permit Application Submitted October 29, 2008•Application was Deemed complete by MT DEQ March 27, 2009•Final Permit for Discharge granted and Effective June 1, 2010 Fresno Reservoir

21

Water Marketing

Contract

Detail Extraction Points, Water Volumes, and Water Quality

DefineStorageRights

USFWS

Volume/Timing

Additional Storage Requirements? Storage Points

Water Rights

Produced Water Rights

6 months

Montana Water Rights

6 months

Hydro-Geologic Assessment6-12 months

North Dakota Water Rights6-12 months

WaterTreatment

Outfall Design1-2 months

Mixing Zone Study1-2 months

Amend Discharge Permit

2 months

R.O. Pilot and Study

2-4 months

Permanent Treatment Facility Design and Build

Right OfWays

1 month

Pipeline Design and Construction

1 month

Iofina Water Marketing Timeline

22

POD’s and stripping facility

23

Iofina Energy Services

24

25

•Admitted to trading on LSE’s AIM on May 9th 2008•Gross funds of £15.1m raised through an

oversubscribed placing of 27.5m shares at 55p giving a free float of 29.3%

•Market capitalization at IPO of £51.6m•Strong international institutional support • IPO proceeds to be used for drilling, extraction and

production operations and new acreage acquisition • Feb 2009 secondary offering £5m for Iodine

derivatives business at 55p

AIM IPO Highlights

Iofina plc Shareholders

26

Corporate Structure

•Current ownership structure

– Incorporated in 2005 and registered in England and Wales under the Companies Act 1985 with registered number 5393357

–105,193,726 shares issued, directors and management own 33%

–100% wholly owned subsidiary Iofina, Inc.

– Iofina Natural Gas, Inc., Iofina Resource, LLC, Iofina Chemical, Inc., Iofina Chemical, LLC, H&S Kentucky Holdings, Inc., and H&S Chemical Co., Inc. are 100% wholly owned subsidiaries of Iofina, Inc.

•Current Financial Strength

–c.290,000 net acres of Iodine and natural gas leases in northern Montana’s Atlantis Prospect

–Strong portfolio of intellectual property

–Owner pipeline, drilling rig, wells, large production facilities and other equipment

–No current or long term debt

27

Management Team

Lance J. BallerCEO and President

Mr. Baller is the former managing partner ofShortline Equity Partners, Inc., a mid-marketmerger and acquisitions consulting andinvestment company in the United States. Hehas actively served on the investmentcommittees, audit committees, committees oncorporate governance, compensation andbenefits committees, executive committees,finance committees, committees on publicpolicy and social responsibility, and on theboard of directors of companies in Asia andUnited States. Mr. Baller is also the former vicepresident of mergers and acquisitions,financing and corporate development atIntegrated Biopharma, Inc and prior to this avice president of the investment banking firmUBS AG and Morgan Stanley. He is the formerchairman and current director of NetAdsInternational, Inc. Mr. Baller is on the board oftrustees of Giant 5 Mutual Funds and alsoserves as the chairman of the audit committeeand as the audit committee financial expertunder the Sarbanes-Oxley Act of the UnitedStates for Giant 5 Funds. Mr. Baller was theformer Finance Director of the Company since2006.

Forest D. DornCEO and President of Iofina Natural Gas, Inc.

Mr. Dorn brings over thirty (30) years of broadoil and gas experience to Iofina. Prior to Mr.Dorn’s appointment he was aMember/Manger of Avanti Exploration, LLCsince 2004. Mr. Dorn began his career withForest Oil Corporation (NYSE: FST US$1.77 bncap) as a scout in Midland, Texas in 1977. Helater became a landman in Midland, and in1980 became Assistant Division Manager ofthe Company's MAFLA (Mississippi, Alabamaand Florida) Division located in Jackson,Mississippi. In 1984 he was appointedAssistant Division Manager of the Company'sSouthern Division located in Lafayette,Louisiana. In 1990 he assumed the position inDenver of Division Manager - OnshoreDivision, and was appointed a Vice Presidentof the Company in 1991, General BusinessManager in December 1993, and Senior VicePresident of the Gulf Coast Region in 1996,and Senior Vice President Corporate Servicesin 2000 until his departure in 2004. Mr. Dornholds a Liberal Arts Degree from theUniversity of Arizona in Tucson where hegraduated in 1977

Dr. Tom BeckerCEO and President of Iofina Chemical, Inc.

Dr. Becker was the former vice president ofResearch and Development at H&S Chemical.Iofina bought H&S in July 2009. Dr. Becker hasstrong relationships in the Iodine derivativesmarkets. Dr. Becker has conducted extensiveresearch in both inorganic and organic halogenbased chemistry. Dr. Becker has written amagnitude of published technical papers in hiscareer. Prior to H&S Dr. Becker worked for theEPA and various other chemical manufacturingcompanies. Dr. Becker earned a BS inChemistry from Indiana University, and a PhDin Chemistry from the University ofCincinnati. He has extensive experience inscale-up of chemical processes from laboratoryto pilot to full scale production and is theinventor on several chemical patents. Listed asinventor of Wellhead Extraction Technology®(WET®) in US patents filed in November 2008

28

Non-Exec ChairmanDr. Chris Fay CBE, PhD, BSc, C.Eng, FREng, FRSE, FICE & FEINon-Executive Chairman

Dr. Fay is the former Chairman of ExproInternational Group plc which was recently sold for £1.8bn to Candover. He served as Chairman from 1999 until the sale in 2008. Dr. Fay is currently a non-executive director of Stena International Sarl, and Brightside Group plc . Dr. Fay left the Board of Anglo-American plc (LSE:AAL, market capitalisation of £19.54 billion) in April 2010, after over 10 years of service, which included Chairman of the S&SD Committee and a member of the Remuneration and Audit Committees for Anglo-American plc. From 1993-1998, Dr. Fay was Chairman and Chief Executive of Shell U.K. Limited, a leading integrated oil, gas and chemical company in the UK with a typical net income of £500 million on a turnover of £9 billion per annum, annual CAPEX of £900 million and 7,000 direct staff. Dr. Fay retired from the Shell Group in February 1999 after 30 years’ service. Dr. Fay was senior non-executive director of BAA plc 1998-2006, during which BAA was sold for £10.3 billion to the Ferrovial Consortium, Chairman of ACBE (Government Advisory Committee on Business and the Environment) 1999-2003 where Dr. Fay championed the launch of the UK’s Emission Trading Scheme in 2002-2003. Educated at Leeds University where he received a BSc and a PhD in civil engineering, Dr. Fay was awarded a CBE in 1999 for services to the gas and oil industry.

Jeff P. PloenNon-Executive Deputy Chairman

Mr. Ploen is currently a director of MomentumBiofuels Inc., a biodiesel producer in HoustonTexas. Mr. Ploen is also a former director ofPetro Uno, a Columbian oil and gas explorationcompany. He was the director of finance atNavidec, Inc., now BPZ Energy, Inc (AMEX: BZP;market capitalisation of $532 million), havingraised more than $150 million in debt from theIFC (World Bank) and $140 million in equity frominstitutional investors. Mr. Ploen is the formerCEO of Tamaron Corp., Paradigm Holdings, Inc.,and Tonga Capital Corp., all of which were soldor merged to substantially larger corporations.

Paul Chase-GardenerNon-Executive Director and Chairman of the Audit Committee

Mr. Chase-Gardener originally co-foundedBrightside Group plc, a leading E insurance directcompany, and now serves as CEO. Prior, Mr.Chase-Gardener was Chairman of Southern RockInsurance Company Limited, New Law LLP(Solicitors), and former Chairman and FinanceDirector of Group Direct LTD. Mr. Chase-Gardener was the former Managing Director anda substantial shareholder of Bladon Group Plcuntil the successful trade sale to InghamsTravel. Mr. Chase-Gardener qualified as aChartered Accountant with Price Waterhouse inLondon where he began his career.